SANTHERA PHARMACEUTICALS HOLDING AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.31 CHF | -0.64% |
|
-2.00% | -5.10% |
| 04-25 | Transcript : Santhera Pharmaceuticals Holding AG, 2023 Earnings Call, Apr 25, 2024 | |
| 04-25 | Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SANTHERA PHARMACEUTICALS HOLDING AG | Specialty & Advanced Pharmaceuticals | -0.64% | -2.00% | -5.10% | +45.47% | -93.73% | 94.61M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- SANN Stock
- Charts Santhera Pharmaceuticals Holding AG
- Comparison Chart
